Maine Medical Center

Scarborough, Maine 04074-7133

1 studies enrolling now · 26 studies all time

What they study most

Advanced Solid Tumor, Advanced, Persistent, or Recurrent Endometrial Cancer, Aneurysm, Aneurysms, Aortic-valve Replacement, Atrial Fibrillation, Brain and Central Nervous System Tumors, Breast Cancer, CIED Related Infection, Complete Response, Complex Congenital Heart Disease, Congenital Heart Disease in Children

Studies at this site

• A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer — Recruiting now
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — Recruiting now
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior — Completed
• A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms — Completed
• Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures — Completed
• Cenobamate Open-Label Extension Study for YKP3089C025 — Completed
• A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations — Completed
• A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer — Stopped early
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals — Completed
• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma — Running, not enrolling
• Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer — Completed
• Behavior of Valve Leaflets Following Aortic Valve Implant — Completed
• Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) — Running, not enrolling
• Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) — Completed
• Vitamin D and Type 2 Diabetes Study — Completed
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• EffectiveNess and SAfety of Small ANeurysm COiling Trial — Status unconfirmed
• Assess Cancer in Ovarian Tumors With Biomarkers. — Completed